In the latest close session, Moderna (MRNA) was down 3.45% at $42.55. The stock's change was less than the S&P 500's daily gain of 0.54%. At the same time, the Dow added 1.05%, and the tech-heavy ...

If you are wondering whether Moderna's share price still reflects its underlying worth, it helps to start with the recent ...

If promising results on a skin cancer vaccine from Moderna and Merck lead to a new launch, the Covid-19 era darling's stock could revive after a 91% fall from its peak.

Moderna Inc (NASDAQ:MRNA) shares are trading higher on Wednesday on continued momentum after the company's Tuesday update revealing the long‑term results from a cancer therapy study.

Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.

Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that provides messenger RNA medicines. Valued at a market cap of $17.2 billion, the company gained global prominence with ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the October 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...